Structure

Physi-Chem Properties

Molecular Weight:  728.12
Volume:  664.009
LogP:  2.25
LogD:  0.796
LogS:  -2.911
# Rotatable Bonds:  12
TPSA:  319.89
# H-Bond Aceptor:  19
# H-Bond Donor:  11
# Rings:  5
# Heavy Atoms:  19

MedChem Properties

QED Drug-Likeness Score:  0.066
Synthetic Accessibility Score:  4.472
Fsp3:  0.182
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.999
MDCK Permeability:  1.1666338650684338e-05
Pgp-inhibitor:  0.069
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.946
20% Bioavailability (F20%):  0.99
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.01
Plasma Protein Binding (PPB):  88.26703643798828%
Volume Distribution (VD):  0.375
Pgp-substrate:  14.982157707214355%

ADMET: Metabolism

CYP1A2-inhibitor:  0.67
CYP1A2-substrate:  0.009
CYP2C19-inhibitor:  0.029
CYP2C19-substrate:  0.023
CYP2C9-inhibitor:  0.487
CYP2C9-substrate:  0.05
CYP2D6-inhibitor:  0.028
CYP2D6-substrate:  0.108
CYP3A4-inhibitor:  0.052
CYP3A4-substrate:  0.006

ADMET: Excretion

Clearance (CL):  13.008
Half-life (T1/2):  0.968

ADMET: Toxicity

hERG Blockers:  0.226
Human Hepatotoxicity (H-HT):  0.168
Drug-inuced Liver Injury (DILI):  0.978
AMES Toxicity:  0.095
Rat Oral Acute Toxicity:  0.001
Maximum Recommended Daily Dose:  0.003
Skin Sensitization:  0.973
Carcinogencity:  0.036
Eye Corrosion:  0.003
Eye Irritation:  0.935
Respiratory Toxicity:  0.006

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC95421

Natural Product ID:  NPC95421
Common Name*:   Hyemaloside A
IUPAC Name:   [(2R,3R,4S,5R,6S)-3-hydroxy-6-(4-hydroxyphenoxy)-4,5-bis[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
Synonyms:  
Standard InCHIKey:  DTLDDZWHEMEXCO-ILYYIXHASA-N
Standard InCHI:  InChI=1S/C33H28O19/c34-15-1-3-16(4-2-15)49-33-29(52-32(47)14-9-21(39)26(43)22(40)10-14)28(51-31(46)13-7-19(37)25(42)20(38)8-13)27(44)23(50-33)11-48-30(45)12-5-17(35)24(41)18(36)6-12/h1-10,23,27-29,33-44H,11H2/t23-,27-,28+,29-,33-/m1/s1
SMILES:  Oc1ccc(cc1)O[C@@H]1O[C@H](COC(=O)c2cc(O)c(c(c2)O)O)[C@H]([C@@H]([C@H]1OC(=O)c1cc(O)c(c(c1)O)O)OC(=O)c1cc(O)c(c(c1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL509744
PubChem CID:   25058097
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27524 Eugenia hyemalis Species Myrtaceae Eukaryota n.a. n.a. n.a. PMID[18763827]
NPO27524 Eugenia hyemalis Species Myrtaceae Eukaryota n.a. whole plant n.a. PMID[18763827]
NPO27524 Eugenia hyemalis Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 = 1460.0 nM PMID[471311]
NPT2 Others Unspecified IC50 = 580.0 nM PMID[471311]
NPT2 Others Unspecified IC50 = 180.0 nM PMID[471311]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC95421 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC198125
0.9684 High Similarity NPC4013
0.9684 High Similarity NPC90905
0.963 High Similarity NPC5786
0.963 High Similarity NPC102851
0.9557 High Similarity NPC289346
0.9506 High Similarity NPC658
0.9506 High Similarity NPC149300
0.9506 High Similarity NPC197708
0.9494 High Similarity NPC287872
0.9494 High Similarity NPC74319
0.9437 High Similarity NPC285108
0.9437 High Similarity NPC33298
0.943 High Similarity NPC172419
0.943 High Similarity NPC238419
0.9401 High Similarity NPC8940
0.9375 High Similarity NPC311803
0.9375 High Similarity NPC472859
0.9375 High Similarity NPC25389
0.9367 High Similarity NPC247629
0.9367 High Similarity NPC239019
0.9313 High Similarity NPC166277
0.9313 High Similarity NPC119125
0.925 High Similarity NPC114791
0.925 High Similarity NPC289811
0.925 High Similarity NPC141331
0.925 High Similarity NPC160780
0.925 High Similarity NPC104222
0.925 High Similarity NPC210501
0.925 High Similarity NPC318826
0.9235 High Similarity NPC111490
0.9235 High Similarity NPC261623
0.9231 High Similarity NPC97119
0.9231 High Similarity NPC297503
0.9231 High Similarity NPC135831
0.9226 High Similarity NPC80956
0.9222 High Similarity NPC472991
0.9222 High Similarity NPC472992
0.9217 High Similarity NPC163165
0.9207 High Similarity NPC473818
0.9193 High Similarity NPC239966
0.9193 High Similarity NPC203020
0.9187 High Similarity NPC133984
0.9187 High Similarity NPC1913
0.9177 High Similarity NPC3746
0.9177 High Similarity NPC205037
0.9177 High Similarity NPC44260
0.9177 High Similarity NPC61152
0.9177 High Similarity NPC16024
0.9176 High Similarity NPC231254
0.9167 High Similarity NPC476622
0.9167 High Similarity NPC476618
0.9167 High Similarity NPC476619
0.9167 High Similarity NPC476623
0.9167 High Similarity NPC476621
0.9167 High Similarity NPC476620
0.9141 High Similarity NPC121290
0.9141 High Similarity NPC227297
0.9123 High Similarity NPC469650
0.9112 High Similarity NPC471030
0.9107 High Similarity NPC472723
0.9102 High Similarity NPC172033
0.9102 High Similarity NPC88560
0.9102 High Similarity NPC175230
0.9096 High Similarity NPC204937
0.9096 High Similarity NPC149011
0.9075 High Similarity NPC160543
0.9075 High Similarity NPC469652
0.9075 High Similarity NPC472724
0.9075 High Similarity NPC93065
0.9075 High Similarity NPC472720
0.9075 High Similarity NPC472721
0.9075 High Similarity NPC31208
0.9074 High Similarity NPC476373
0.907 High Similarity NPC260521
0.907 High Similarity NPC65489
0.907 High Similarity NPC469649
0.9068 High Similarity NPC472860
0.9064 High Similarity NPC470416
0.9053 High Similarity NPC37668
0.9053 High Similarity NPC472387
0.9053 High Similarity NPC253521
0.9053 High Similarity NPC113836
0.9048 High Similarity NPC169645
0.9048 High Similarity NPC84482
0.9042 High Similarity NPC47140
0.9042 High Similarity NPC67134
0.9017 High Similarity NPC240200
0.9017 High Similarity NPC477081
0.9017 High Similarity NPC290289
0.9017 High Similarity NPC158214
0.9017 High Similarity NPC223534
0.9017 High Similarity NPC477083
0.9012 High Similarity NPC474093
0.9012 High Similarity NPC104910
0.9006 High Similarity NPC36138
0.9 High Similarity NPC194095
0.9 High Similarity NPC327032
0.9 High Similarity NPC191046
0.8994 High Similarity NPC61904
0.8994 High Similarity NPC144097
0.8994 High Similarity NPC79736
0.8994 High Similarity NPC67629
0.8994 High Similarity NPC297574
0.8988 High Similarity NPC470438
0.8988 High Similarity NPC472993
0.8976 High Similarity NPC311389
0.8976 High Similarity NPC128403
0.8976 High Similarity NPC470271
0.897 High Similarity NPC142614
0.8966 High Similarity NPC187632
0.8963 High Similarity NPC476372
0.8963 High Similarity NPC476371
0.896 High Similarity NPC30011
0.896 High Similarity NPC97817
0.896 High Similarity NPC179947
0.896 High Similarity NPC475179
0.896 High Similarity NPC72554
0.8957 High Similarity NPC24164
0.8951 High Similarity NPC68324
0.8951 High Similarity NPC114179
0.8951 High Similarity NPC156818
0.8951 High Similarity NPC160512
0.8951 High Similarity NPC289322
0.8951 High Similarity NPC38779
0.8947 High Similarity NPC469371
0.8941 High Similarity NPC267680
0.8941 High Similarity NPC196127
0.8941 High Similarity NPC217387
0.8941 High Similarity NPC267549
0.8941 High Similarity NPC293626
0.8941 High Similarity NPC258044
0.8941 High Similarity NPC35167
0.8938 High Similarity NPC310661
0.8938 High Similarity NPC105827
0.8935 High Similarity NPC34267
0.8935 High Similarity NPC81042
0.8935 High Similarity NPC214621
0.8935 High Similarity NPC223426
0.8931 High Similarity NPC140151
0.8929 High Similarity NPC254540
0.8929 High Similarity NPC211594
0.8929 High Similarity NPC65333
0.8929 High Similarity NPC259152
0.8929 High Similarity NPC172807
0.8929 High Similarity NPC3583
0.8924 High Similarity NPC92117
0.8916 High Similarity NPC175793
0.8914 High Similarity NPC471091
0.8914 High Similarity NPC40078
0.8914 High Similarity NPC97924
0.8914 High Similarity NPC264302
0.8908 High Similarity NPC119094
0.8908 High Similarity NPC473618
0.8908 High Similarity NPC173872
0.8908 High Similarity NPC7839
0.8908 High Similarity NPC142291
0.8895 High Similarity NPC470718
0.8895 High Similarity NPC123259
0.8895 High Similarity NPC35924
0.8895 High Similarity NPC199172
0.8895 High Similarity NPC162394
0.8895 High Similarity NPC241781
0.8895 High Similarity NPC156785
0.8895 High Similarity NPC129533
0.8895 High Similarity NPC132111
0.8889 High Similarity NPC300845
0.8889 High Similarity NPC88803
0.8889 High Similarity NPC291948
0.8889 High Similarity NPC104983
0.8889 High Similarity NPC471405
0.8889 High Similarity NPC250436
0.8876 High Similarity NPC98583
0.8875 High Similarity NPC134905
0.8875 High Similarity NPC36130
0.8869 High Similarity NPC470272
0.8869 High Similarity NPC471416
0.8869 High Similarity NPC34287
0.8862 High Similarity NPC146792
0.8862 High Similarity NPC43918
0.8862 High Similarity NPC190204
0.8862 High Similarity NPC45618
0.8862 High Similarity NPC58716
0.8862 High Similarity NPC261411
0.8862 High Similarity NPC116745
0.8861 High Similarity NPC120621
0.8861 High Similarity NPC248257
0.8861 High Similarity NPC142528
0.8848 High Similarity NPC148273
0.8844 High Similarity NPC21359
0.8844 High Similarity NPC249560
0.8844 High Similarity NPC470713
0.8844 High Similarity NPC470720
0.8844 High Similarity NPC223860
0.8844 High Similarity NPC470451
0.8844 High Similarity NPC275977
0.8844 High Similarity NPC470455
0.8844 High Similarity NPC25946
0.8844 High Similarity NPC470717
0.8844 High Similarity NPC460984

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC95421 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8929 High Similarity NPD7993 Clinical (unspecified phase)
0.8889 High Similarity NPD4868 Clinical (unspecified phase)
0.8824 High Similarity NPD4338 Clinical (unspecified phase)
0.8647 High Similarity NPD7472 Approved
0.8596 High Similarity NPD6797 Phase 2
0.8588 High Similarity NPD7054 Approved
0.8547 High Similarity NPD7251 Discontinued
0.8538 High Similarity NPD7074 Phase 3
0.8529 High Similarity NPD3818 Discontinued
0.8497 Intermediate Similarity NPD7808 Phase 3
0.8383 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD1653 Approved
0.8304 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8304 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8304 Intermediate Similarity NPD6166 Phase 2
0.8266 Intermediate Similarity NPD5844 Phase 1
0.8229 Intermediate Similarity NPD7685 Pre-registration
0.8136 Intermediate Similarity NPD8313 Approved
0.8136 Intermediate Similarity NPD8312 Approved
0.8095 Intermediate Similarity NPD2801 Approved
0.8095 Intermediate Similarity NPD8455 Phase 2
0.8086 Intermediate Similarity NPD6190 Approved
0.8061 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8057 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8036 Intermediate Similarity NPD1934 Approved
0.8022 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7228 Approved
0.7988 Intermediate Similarity NPD1465 Phase 2
0.7988 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7941 Intermediate Similarity NPD5402 Approved
0.7921 Intermediate Similarity NPD6559 Discontinued
0.7862 Intermediate Similarity NPD230 Phase 1
0.7845 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD7266 Discontinued
0.7836 Intermediate Similarity NPD3817 Phase 2
0.7816 Intermediate Similarity NPD7199 Phase 2
0.7811 Intermediate Similarity NPD4380 Phase 2
0.7803 Intermediate Similarity NPD6234 Discontinued
0.7791 Intermediate Similarity NPD3882 Suspended
0.7784 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD1511 Approved
0.7746 Intermediate Similarity NPD7075 Discontinued
0.7719 Intermediate Similarity NPD37 Approved
0.7697 Intermediate Similarity NPD3751 Discontinued
0.7688 Intermediate Similarity NPD4965 Approved
0.7688 Intermediate Similarity NPD4967 Phase 2
0.7688 Intermediate Similarity NPD4966 Approved
0.768 Intermediate Similarity NPD8151 Discontinued
0.7679 Intermediate Similarity NPD1512 Approved
0.767 Intermediate Similarity NPD6232 Discontinued
0.767 Intermediate Similarity NPD3787 Discontinued
0.7661 Intermediate Similarity NPD7411 Suspended
0.7657 Intermediate Similarity NPD5494 Approved
0.7627 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD7240 Approved
0.7614 Intermediate Similarity NPD6959 Discontinued
0.759 Intermediate Similarity NPD4628 Phase 3
0.7586 Intermediate Similarity NPD7768 Phase 2
0.7572 Intermediate Similarity NPD7819 Suspended
0.7572 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD7473 Discontinued
0.7529 Intermediate Similarity NPD5403 Approved
0.7529 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD6801 Discontinued
0.7513 Intermediate Similarity NPD7783 Phase 2
0.7513 Intermediate Similarity NPD7435 Discontinued
0.7513 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD1549 Phase 2
0.7469 Intermediate Similarity NPD1613 Approved
0.7469 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD6799 Approved
0.7448 Intermediate Similarity NPD6780 Approved
0.7448 Intermediate Similarity NPD6778 Approved
0.7448 Intermediate Similarity NPD6782 Approved
0.7448 Intermediate Similarity NPD6781 Approved
0.7448 Intermediate Similarity NPD6776 Approved
0.7448 Intermediate Similarity NPD6777 Approved
0.7448 Intermediate Similarity NPD6779 Approved
0.7443 Intermediate Similarity NPD3749 Approved
0.7412 Intermediate Similarity NPD5401 Approved
0.741 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7385 Intermediate Similarity NPD7870 Phase 2
0.7385 Intermediate Similarity NPD7871 Phase 2
0.7381 Intermediate Similarity NPD3750 Approved
0.7374 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD7874 Approved
0.7333 Intermediate Similarity NPD7697 Approved
0.7333 Intermediate Similarity NPD7680 Approved
0.7333 Intermediate Similarity NPD7696 Phase 3
0.7333 Intermediate Similarity NPD7698 Approved
0.7321 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD6233 Phase 2
0.7284 Intermediate Similarity NPD3027 Phase 3
0.7278 Intermediate Similarity NPD9269 Phase 2
0.7273 Intermediate Similarity NPD7701 Phase 2
0.7246 Intermediate Similarity NPD1551 Phase 2
0.7241 Intermediate Similarity NPD7458 Discontinued
0.7239 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD5353 Approved
0.7222 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD1933 Approved
0.7209 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD6599 Discontinued
0.7194 Intermediate Similarity NPD6823 Phase 2
0.7188 Intermediate Similarity NPD6534 Approved
0.7188 Intermediate Similarity NPD6535 Approved
0.7186 Intermediate Similarity NPD1510 Phase 2
0.7176 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD7699 Phase 2
0.7165 Intermediate Similarity NPD7700 Phase 2
0.7164 Intermediate Similarity NPD7801 Approved
0.716 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD9494 Approved
0.7143 Intermediate Similarity NPD2935 Discontinued
0.7143 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2796 Approved
0.7143 Intermediate Similarity NPD8434 Phase 2
0.7127 Intermediate Similarity NPD8127 Discontinued
0.7108 Intermediate Similarity NPD447 Suspended
0.7101 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.71 Intermediate Similarity NPD7585 Approved
0.7083 Intermediate Similarity NPD3748 Approved
0.7059 Intermediate Similarity NPD7039 Approved
0.7059 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7038 Approved
0.7053 Intermediate Similarity NPD8150 Discontinued
0.705 Intermediate Similarity NPD7583 Approved
0.7049 Intermediate Similarity NPD5242 Approved
0.7048 Intermediate Similarity NPD943 Approved
0.7035 Intermediate Similarity NPD8320 Phase 1
0.7035 Intermediate Similarity NPD8319 Approved
0.7026 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD9268 Approved
0.7024 Intermediate Similarity NPD7097 Phase 1
0.7021 Intermediate Similarity NPD7549 Discontinued
0.7 Intermediate Similarity NPD1091 Approved
0.6977 Remote Similarity NPD8166 Discontinued
0.6971 Remote Similarity NPD6273 Approved
0.6966 Remote Similarity NPD6386 Approved
0.6966 Remote Similarity NPD6385 Approved
0.6965 Remote Similarity NPD7584 Approved
0.6959 Remote Similarity NPD6213 Phase 3
0.6959 Remote Similarity NPD6212 Phase 3
0.6959 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6957 Remote Similarity NPD3926 Phase 2
0.6947 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6946 Remote Similarity NPD1240 Approved
0.694 Remote Similarity NPD1247 Approved
0.6928 Remote Similarity NPD3764 Approved
0.6928 Remote Similarity NPD6798 Discontinued
0.6923 Remote Similarity NPD919 Approved
0.6914 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6914 Remote Similarity NPD2533 Approved
0.6914 Remote Similarity NPD2532 Approved
0.6914 Remote Similarity NPD2534 Approved
0.6909 Remote Similarity NPD4908 Phase 1
0.6879 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6868 Remote Similarity NPD6971 Discontinued
0.6864 Remote Similarity NPD1607 Approved
0.6855 Remote Similarity NPD9545 Approved
0.6854 Remote Similarity NPD3226 Approved
0.6829 Remote Similarity NPD1203 Approved
0.6826 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6825 Remote Similarity NPD5953 Discontinued
0.6821 Remote Similarity NPD6674 Discontinued
0.6821 Remote Similarity NPD1652 Phase 2
0.6811 Remote Similarity NPD7229 Phase 3
0.68 Remote Similarity NPD7440 Discontinued
0.6778 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6768 Remote Similarity NPD3225 Approved
0.6761 Remote Similarity NPD7390 Discontinued
0.676 Remote Similarity NPD3455 Phase 2
0.6755 Remote Similarity NPD7177 Discontinued
0.6748 Remote Similarity NPD1481 Phase 2
0.6748 Remote Similarity NPD1608 Approved
0.6742 Remote Similarity NPD920 Approved
0.6723 Remote Similarity NPD642 Clinical (unspecified phase)
0.6723 Remote Similarity NPD7422 Clinical (unspecified phase)
0.672 Remote Similarity NPD7286 Phase 2
0.6707 Remote Similarity NPD6832 Phase 2
0.6706 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6706 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6706 Remote Similarity NPD5124 Phase 1
0.6698 Remote Similarity NPD8059 Phase 3
0.6698 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6687 Remote Similarity NPD1535 Discovery
0.6686 Remote Similarity NPD651 Clinical (unspecified phase)
0.6686 Remote Similarity NPD7033 Discontinued
0.6686 Remote Similarity NPD7003 Approved
0.6667 Remote Similarity NPD4288 Approved
0.6667 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4357 Discontinued
0.6648 Remote Similarity NPD6844 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data